Pragmatic management of hyperglycaemia in acute ischaemic stroke: Safety and feasibility of intensive intravenous insulin treatment

Cerebrovascular Diseases

Volumn 27, Issue 2, 2009, Pages 167-175

  Kreisel, Stefan H ^a   Berschin, Undine M ^a   Hammes, Hans Peter ^a   Leweling, Hans ^a   Bertsch, Thomas ^c   Hennerici, Michael G ^a   Schwarz, Stefan ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c KLINIKUM NÜRNBERG   (Germany)

Author keywords

Brain infarction; Hyperglycaemia; Insulin

Indexed keywords

GLUCOSE; INSULIN;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COLD SWEAT; DIABETES MELLITUS; DRUG SAFETY; DRUG WITHDRAWAL; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INCIDENCE; INSULIN TREATMENT; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE UNIT; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ALGORITHMS; BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEASIBILITY STUDIES; FEMALE; HOSPITAL UNITS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; PATIENT CARE TEAM; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 57649135334     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000185608     Document Type: Article

References (28)

1. Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, Hansen MD: Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999;52:280-284.
2. Melamed E: Reactive hyperglycaemia in patients with acute stroke. J Neurol Sci 1976;29:267-275.
3. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM: Persistent post-stroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-2214.
4. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426-2432.
5. Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, Fineberg SE, Tierney WR: Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002;59:67-71.
6. Murros K, Fogelholm R, Kettunen S, Vuorela AL: Serum cortisol and outcome of ischemic brain infarction. J Neurol Sci 1993;116:12-17.
7. Christensen H, Boysen G: Blood glucose increases early after stroke onset: a study on serial measurements of blood glucose in acute stroke. Eur J Neurol 2002;9:297-301.
8. Allport LE, Butcher KS, Baird TA, MacGregor L, Desmond PM, Tress BM, Colman P, Davis SM: Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke 2004;35:1886-1891.
9. Gray CS, French JM, Bates D, Cartlidge NE, Venables GS, James OF: Increasing age, diabetes mellitus and recovery from stroke. Postgrad Med J 1989;65:720-724.
10. Matchar DB, Divine GW, Heyman A, Feussner JR: The influence of hyperglycemia on outcome of cerebral infarction. Ann Intern Med 1992;117:449-456.
11. Toni D, Chamorro A, Kaste M, Lees K, Wahlgren NG, Hacke W: Acute treatment of ischaemic stroke. European stroke initiative. Cerebrovasc Dis 2004;17(suppl 2):30-46.
12. Adams HP Jr, del Zoppo GJ, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida R, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EFM: Guidelines for the early management of patients with ischemic stroke. Stroke 2007;38:1655-1711.
13. Pittas AG, Siegel RD, Lau J: Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2004;164:2005-2011.
14. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461.
15. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
16. Walters MR, Weir CJ, Lees K: A randomized, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycemic acute ischaemic stroke patients. Cerebrovasc Dis 2006;22:116-122.
17. Bruno A, Saha C, Williams LS, Shankar R: IV insulin during acute cerebral infarction in diabetic patients. Neurology 2004;62:1441-1442.
18. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS: Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the glucose insulin in stroke trial (GIST). Stroke 1999;30:793-799.
19. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti GK: Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007;6:397-406.
20. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. JAMA 1998;279:1265-1272.
21. Wardlaw JM, Dennis MS, Lindley RI, Sellar RJ, Warlow CP: The validity of a simple clinical classification of acute ischaemic stroke. J Neurol 1996;243:274-279.
22. Signorini D: Sample size for poisson regression. Biometrika 1991;78:446-450.
23. Queale WS, Seidler AJ, Brancati FL: Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 1997;157:545-552.
24. Watkinson P, Barber VS, Young JD: Strict glucose control in the critically ill. BMJ 2006;332:865-866.
25. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003;31:359-366.
26. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE: Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-982.
27. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M: Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006;55:3151-3159.
28. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fischer M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenstrom A: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005;26:650-661.